Aligos Therapeutics Statistics

Total Valuation

ALGS has a market cap or net worth of $27.39 million. The enterprise value is -$102.59 million.

Market Cap	27.39M
Enterprise Value	-102.59M

Important Dates

The last earnings date was Tuesday, May 6, 2025, before market open.

Earnings Date	May 6, 2025
Ex-Dividend Date	n/a

Share Statistics

ALGS has 6.11 million shares outstanding.

Current Share Class	5.31M
Shares Outstanding	6.11M
Shares Change (YoY)	n/a
Shares Change (QoQ)	n/a
Owned by Insiders (%)	2.91%
Owned by Institutions (%)	23.16%
Float	3.84M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	8.38
Forward PS	20.14
PB Ratio	0.24
P/TBV Ratio	0.24
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 7.56, with a Debt / Equity ratio of 0.07.

Current Ratio	7.56
Quick Ratio	7.28
Debt / Equity	0.07
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is -60.44% and return on invested capital (ROIC) is -55.47%.

Return on Equity (ROE)	-60.44%
Return on Assets (ROA)	-38.74%
Return on Invested Capital (ROIC)	-55.47%
Return on Capital Employed (ROCE)	-65.54%
Revenue Per Employee	$46,714
Profits Per Employee	-$760,857
Employee Count	70
Asset Turnover	0.02
Inventory Turnover	n/a

Taxes

In the past 12 months, ALGS has paid $350,000 in taxes.

Income Tax	350,000
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -77.12% in the last 52 weeks. The beta is 2.76, so ALGS's price volatility has been higher than the market average.

Beta (5Y)	2.76
52-Week Price Change	-77.12%
50-Day Moving Average	8.03
200-Day Moving Average	16.51
Relative Strength Index (RSI)	35.72
Average Volume (20 Days)	135,811

Short Selling Information

The latest short interest is 835,744, so 13.67% of the outstanding shares have been sold short.

Short Interest	835,744
Short Previous Month	831,999
Short % of Shares Out	13.67%
Short % of Float	21.77%
Short Ratio (days to cover)	4.58

Income Statement

In the last 12 months, ALGS had revenue of $3.27 million and -$53.26 million in losses.

Revenue	3.27M
Gross Profit	-67.00M
Operating Income	-86.35M
Pretax Income	-75.52M
Net Income	-53.26M
EBITDA	-85.41M
EBIT	-86.35M
Earnings Per Share (EPS)	n/a

Full Income Statement

Balance Sheet

The company has $137.86 million in cash and $7.87 million in debt, giving a net cash position of $129.99 million or $21.26 per share.

Cash & Cash Equivalents	137.86M
Total Debt	7.87M
Net Cash	129.99M
Net Cash Per Share	$21.26
Equity (Book Value)	116.45M
Book Value Per Share	n/a
Working Capital	124.26M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$78.91 million and capital expenditures -$104,000, giving a free cash flow of -$79.01 million.

Operating Cash Flow	-78.91M
Capital Expenditures	-104,000
Free Cash Flow	-79.01M
FCF Per Share	-$12.92

Full Cash Flow Statement

Margins

Gross Margin	n/a
Operating Margin	-2,640.70%
Pretax Margin	-1,618.04%
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

ALGS does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	n/a
Shareholder Yield	n/a
Earnings Yield	-194.44%
FCF Yield	-288.44%

Analyst Forecast

The average price target for ALGS is $70.00, which is 1,462.50% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$70.00
Price Target Difference	1,462.50%
Analyst Consensus	Strong Buy
Analyst Count	1
Revenue Growth Forecast (5Y)	131.36%
EPS Growth Forecast (5Y)	n/a

Stock Forecasts

Stock Splits

The last stock split was on August 19, 2024. It was a reverse split with a ratio of 0.04:1.

Last Split Date	Aug 19, 2024
Split Type	Reverse
Split Ratio	0.04:1

Scores

Altman Z-Score	n/a
Piotroski F-Score	1